NegotiumAI is an innovative platform designed to streamline the relationship between advanced therapy drug developers and contract manufacturers. Using cutting-edge AI-driven technologies, we provide transparency, reduce costs, and optimize decision-making by delivering real-time market intelligence. Our scalable business model offers subscription-based insights and marketplace access, benefiting both buyers and sellers in the highly fragmented contract manufacturing industry. With deep expertise in procurement, supply chain, and advanced therapeutics, NegotiumAI is committed to driving efficiencies and supporting the growth of over 1,300 new advanced therapy manufacturing deals annually.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://negotium.ai
- Keywords
- IT Consulting.
Negotiumai Questions
Negotiumai's website is http://negotium.ai
Negotiumai's LinkedIn profile is https://www.linkedin.com/company/negotiumai
Negotiumai has
2 employees.
View email and phone details for 2
employees at Negotiumai.
Negotiumai's industry is
Biotechnology Research
Negotiumai's top competitors are
Negotiumbio,
百明信康生物技术（杭州）有限公司 Worgpharma,
Probity Advisors, Inc.,
Raffles Pharmatech,
Caroffer,
Sicarius,
T-Knife Therapeutics,
Tigen,
Photon & Polymers,
Transgene.
Negotiumai's categories are Biotechnology Research
Negotiumai's founding year is 2023
